<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Reproductive BioMedicine</title>
<title_fa>International Journal of Reproductive BioMedicine</title_fa>
<short_title>IJRM</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijrm.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2476-4108</journal_id_issn>
<journal_id_issn_online>2476-3772</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/ijrm</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<volume>23</volume>
<number>9</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa>مقایسه عملکرد جنسی در زنان بارور و نابارور مبتلا به سندرم تخمدان پلی‌کیستیک: یک مطالعه مقطعی</title_fa>
	<title>Comparison of sexual function in fertile and infertile women with polycystic ovary syndrome: A cross-sectional study</title>
	<subject_fa></subject_fa>
	<subject>Fertility &amp; Infertility</subject>
	<content_type_fa>Original Article</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;text-justify:inter-ideograph&quot;&gt;&lt;span style=&quot;direction:rtl&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;مقدمه: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;سندرم تخمدان پلی&amp;shy;کیستیک (&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;PCOS&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;) یک اختلال هورمونی شایع است که تقریباً 2/9% از زنان در سن باروری را تحت تأثیر قرار می&amp;shy;دهد. تغییرات فیزیکی و روانی ناشی از &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;PCOS&lt;/span&gt; &lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;ممکن است عملکرد جنسی زنان را مختل کند. زنان مبتلا به &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;PCOS&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; ممکن است با یکی از مهمترین عوارض این بیماری یعنی ناباروری مواجه شوند.&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;text-justify:inter-ideograph&quot;&gt;&lt;span style=&quot;direction:rtl&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;هدف: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;این مطالعه با هدف مقایسه عملکرد جنسی بین زنان بارور و نابارور مبتلا به &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;PCOS&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; انجام شد.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;text-justify:inter-ideograph&quot;&gt;&lt;span style=&quot;direction:rtl&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;مواد و روش&amp;shy; ها: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;این مطالعه مقطعی بر روی ۳۶۴ زن بارور و ۲۳۹ زن نابارور مبتلا به &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;PCOS&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; که از فروردین تا بهمن ۱۳۹۸ به کلینیک&amp;shy;های زنان بیمارستان آرش تهران مراجعه کرده بودند، انجام شد. شرکت&amp;shy;کنندگان بر اساس وضعیت باروری به دو گروه تقسیم شدند: گروه بارور (۳۶۴ &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;= &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;n&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;) و گروه نابارور (۲۳۹ &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;= &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;n&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;). از شرکت&amp;shy;کنندگان خواسته شد پرسشنامه&amp;shy;های اطلاعات دموگرافیک و شاخص عملکرد جنسی زنان (&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;FSFI&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;) را تکمیل کنند. در نهایت شاخص عملکرد جنسی و متغیرهای دموگرافیک در دو گروه مقایسه گردید.&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;text-justify:inter-ideograph&quot;&gt;&lt;span style=&quot;direction:rtl&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;نتایج: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;نمره کل &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;FSFI&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; در زنان بارور و نابارور به ترتیب ۲۶/۶ &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;&amp;plusmn;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; ۷۰/۲۳ و ۰۴/۴ &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;&amp;plusmn;&lt;/span&gt; &lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;۶۵/۲۴ بود. از نظر نمره کل &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;FSFI&lt;/span&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; (391/0 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;= &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;p&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;)&lt;/span&gt;&lt;/span&gt; &lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;و زیرمقیاس&amp;shy;های آن شامل میل جنسی (863/0 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;= &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;p&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;)، رطوبت (583/0 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;= &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;p&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;)، رضایت (118/0 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;= &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;p&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;)، ارگاسم (901/0 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;= &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;p&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;) و تحریک جنسی (405/0 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;= &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;p&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;)، تفاوت آماری معنی&amp;shy;داری بین 2 گروه مشاهده نشد. با این حال، نمره درد در گروه بارور به طور معنی&amp;shy;داری بالاتر بود (001/0 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;&gt; &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;p&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;، 11/1 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;&amp;plusmn;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; 10/3 در مقابل 27/1 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;&amp;plusmn;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; 51/3).&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;b&gt;&lt;span dir=&quot;RTL&quot; lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;نتیجه&amp;shy; گیری: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span dir=&quot;RTL&quot; lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;اختلال عملکرد جنسی در زنان نابارور مبتلا به &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;PCOS&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;RTL&quot; lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; ممکن است بیشتر با عوارض مرتبط با &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;PCOS&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;RTL&quot; lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; و سایر عوامل همزمان مؤثر بر عملکرد جنسی مرتبط باشد تا خود ناباروری. به نظر می&amp;shy;رسد تأثیر ناباروری بر عملکرد جنسی می&amp;shy;تواند در زنان نابارور با توجه به شرایط هر فرد متفاوت باشد. بنابراین، غربالگری اختلال عملکرد جنسی در زنان مبتلا به &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;PCOS&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;RTL&quot; lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; و ناباروری باید به عنوان بخشی از ارزیابی بالینی در نظر گرفته شود تا منجر به تشخیص زودهنگام و بهبود کیفیت زندگی آنان گردد.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Background: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Polycystic ovarian syndrome (PCOS) is a common hormonal disorder that affects approximately 9.2% of women of childbearing age. Physical and psychological changes caused by PCOS might impair women&amp;rsquo;s sexual function. Women with PCOS may experience one of the most significant complications&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;RTL&quot; lang=&quot;FA&quot; style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;,&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt; which is infertility.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Objective:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;This study aimed to compare sexual function between fertile and infertile women diagnosed with PCOS.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Materials and Methods:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;This cross-sectional study involved 364 fertile and 239 infertile women with PCOS who referred to the Arash hospital gynecological clinics, Tehran, Iran from April 2019-February 2020. Participants were divided into 2 groups based on fertility: the fertile group (n = 364) and the infertile group (n = 239). They were asked to fill out a demographic survey and the female sexual function index (FSFI) questionnaires. Finally, the sexual performance index and demographic variables were compared between groups.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Results:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt; The total FSFI score for fertile and infertile women was 23.70 &amp;plusmn; 6.26 and 24.65 &amp;plusmn; 4.04, respectively. Regarding FSFI, the differences between the 2 groups were not statistically significant in terms of total FSFI score (p = 0.391), desire (p = 0.863), lubrication (p = 0.583), satisfaction (p = 0.118), orgasm (p = 0.901), and arousal score (p = 0.405). However, the pain score was significantly higher in the fertile group (3.51 &amp;plusmn; 1.27, 3.10 &amp;plusmn; 1.11, p &lt; 0.001).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:107%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Conclusion:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:107%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt; &lt;span style=&quot;font-family:Times New Roman;&quot;&gt;Impaired sexual function in infertile women diagnosed with PCOS can be more associated with PCOS-related complications and other concurrent factors that affect sexual function rather than infertility. It seems that the effects of infertility on sexual function can be different in infertile women according to each person&amp;#39;s condition. Hence, screening for sexual dysfunction in women with PCOS and infertility should be &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:107%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;deemed as a part of clinical assessment, leading to early diagnosis and improving their quality of life.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa>سندرم تخمدان پلی‌کیستیک, ناباروری, عملکرد جنسی زنان, سلامت باروری, شاخص عملکرد جنسی زنان.</keyword_fa>
	<keyword>Polycystic ovary syndrome, Infertility, Female sexual function, Reproductive health, Female sexual function index.</keyword>
	<start_page>739</start_page>
	<end_page>748</end_page>
	<web_url>http://ijrm.ir/browse.php?a_code=A-10-55-11&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Khadijeh </first_name>
	<middle_name></middle_name>
	<last_name>Azarbayjani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>khadijeazarbyjani@gmail.com</email>
	<code></code>
	<orcid>0000-0003-2307-2667</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Shahideh </first_name>
	<middle_name></middle_name>
	<last_name>Jahanian Sadatmahalleh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Shahideh.Jahanian@modares.ac.ir</email>
	<code></code>
	<orcid>0000-0002-7006-8487</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Negin </first_name>
	<middle_name></middle_name>
	<last_name>Mirzaei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>neginmirzaie75@gmail.com</email>
	<code></code>
	<orcid>0000-0001-7840-779x</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Robinson Research Institute, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mahsa </first_name>
	<middle_name></middle_name>
	<last_name>Yarjanly</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mahsayarjanli@gmail.com</email>
	<code></code>
	<orcid>0009-0008-9078-0800</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Nadia </first_name>
	<middle_name></middle_name>
	<last_name>Jahangiri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>nadiajahangiri@gmail.com</email>
	<code></code>
	<orcid>0000-0003-4768-1571</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Malihe </first_name>
	<middle_name></middle_name>
	<last_name>Nasiri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>malihenasiri@gmail.com</email>
	<code></code>
	<orcid>0000-0003-1496-7442</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Basic Sciences, Faculty of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mona </first_name>
	<middle_name></middle_name>
	<last_name>Zeinaloo</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>moonazeinaloo@gmail.com</email>
	<code></code>
	<orcid>0009-0008-8212-2971</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Community and Preventive Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
